🔗 Share this article Prestigious Award Recognizes Groundbreaking Body's Defenses Research This year's Nobel Prize in medical science was awarded for revolutionary discoveries that illuminate how the immune system targets harmful infections while protecting the healthy tissues. A trio of renowned researchers—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this honor. The work identified specialized "sentinels" within the immune system that remove malfunctioning immune cells capable of harming the body. These discoveries are now paving the way for new therapies for immune disorders and malignancies. These laureates will divide a prize fund worth 11 million Swedish kronor. Decisive Findings "The work has been decisive for understanding how the body's defenses operates and the reason we don't all develop severe self-attack conditions," stated the head of the award panel. The trio's research address a fundamental question: How does the immune system defend us from numerous infections while keeping our healthy cells intact? Our immune system uses immune cells that search for indicators of disease, even pathogens and germs it has never encountered. These defenders utilize sensors—called recognition units—that are produced by chance in countless combinations. This provides the immune system the capacity to fight a wide array of threats, but the unpredictability of the mechanism inevitably produces immune cells that can attack the host. Protectors of the Immune System Researchers earlier knew that some of these harmful defense cells were destroyed in the thymus—the site where immune cells develop. The latest Nobel Prize recognizes the identification of T-reg cells—known as the immune system's "security guards"—which travel through the system to disarm other immune cells that assault the healthy cells. We know that this mechanism fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA. A prize committee added, "The findings have established a new field of investigation and spurred the creation of innovative therapies, for instance for cancer and immune disorders." Regarding malignancies, regulatory T-cells block the system from attacking the growth, so studies are focused on reducing their quantity. For autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is not under attack. A similar method could also be effective in minimizing the risks of transplanted organ failure. Innovative Experiments Professor Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their thymus removed, causing autoimmune disease. He demonstrated that introducing defense cells from healthy animals could stop the disease—implying there was a system for blocking immune cells from harming the body. Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and people that resulted in the discovery of a gene critical for the way T-regs operate. "The pioneering work has uncovered how the body's defenses is controlled by regulatory T cells, preventing it from accidentally targeting the body's own tissues," said a prominent physiology expert. "The work is a striking illustration of how basic physiological research can have far-reaching implications for human health."